Maito, Nasheed A.

HRN: 27-59-19  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/06/2026
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
03/06/2026
03/13/2026
IV DRIP
250mg
Q6
PCAP-C
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines